Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 14 - 20 |
| Updated: | 5/26/2016 |
| Start Date: | January 2016 |
| End Date: | November 2016 |
In this study the investigators will compare a novel approach using daily financial
incentives and a tiered sponsor network to motivate adolescents and young adults with type 1
diabetes to improve glycemic control.
incentives and a tiered sponsor network to motivate adolescents and young adults with type 1
diabetes to improve glycemic control.
Participants will be given daily glucose monitoring goals of ≥4 glucose checks per day with
≥1 readings within goal range (70-180 mg/dL) and provided with iHealth wireless glucometers.
Half of the study participants will be randomized to the 3-month intervention arm on Way to
Health. The intervention includes daily financial incentives ($60 in an account at beginning
of each month with $2 daily loss if non-adherent) and a 2-level tiered sponsor network
(youth select 2 people who will be notified of non-adherence after 2 and 5 consecutive
days). The primary outcome will be HbA1c at 3 months compared to baseline. Secondary
outcomes will include HbA1c at 6 months and the proportion of participants adherent to daily
glucose monitoring goals. Exit interviews will elicit intervention feasibility and feedback
from a youth perspective.
≥1 readings within goal range (70-180 mg/dL) and provided with iHealth wireless glucometers.
Half of the study participants will be randomized to the 3-month intervention arm on Way to
Health. The intervention includes daily financial incentives ($60 in an account at beginning
of each month with $2 daily loss if non-adherent) and a 2-level tiered sponsor network
(youth select 2 people who will be notified of non-adherence after 2 and 5 consecutive
days). The primary outcome will be HbA1c at 3 months compared to baseline. Secondary
outcomes will include HbA1c at 6 months and the proportion of participants adherent to daily
glucose monitoring goals. Exit interviews will elicit intervention feasibility and feedback
from a youth perspective.
Inclusion Criteria:
- Diagnosis of type 1 diabetes
- HbA1c of 8 or greater
- Receiving care from the Childrens Hospital of Philadelphia Diabetes Center
- English-speaking
- Owns a smartphone
Exclusion Criteria:
- New diagnosis of type 1 diabetes within past year
- Unable to provide informed consent
- Already participating in another study to improve glycemic control
- Any medical conditions that would prevent completion of the study
We found this trial at
1
site
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
Click here to add this to my saved trials
